Mutations within the hepatitis B virus genome among chronic hepatitis B patients with hepatocellular carcinoma
✍ Scribed by Jonas Bläckberg; Karin Kidd-Ljunggren
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 173 KB
- Volume
- 71
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Chronic hepatitis B infection is a major cause of hepatocellular cancer (HCC). The pathogenesis of the carcinogenesis is not fully understood. Viral proteins such as the X protein and the truncated middle S protein have been implicated to be transactivators. In order to investigate whether any mutations within relevant parts of the hepatitis B virus (HBV) genome could be associated with the development of HCC, the genomes of 16 HBV strains from chronic HBV carriers with HCC were studied. Serum samples were subjected to PCR and the HBV DNA sequenced subsequently. Genotypes A–D were represented. The sequence analysis showed that an especially high proportion, 50% (CI 95%, 25–75%), of the patients with HCC carried HBV mutants with deletions or insertions in the N‐terminal half of the pre‐S2 region or had a point mutation in the start codon of pre‐S2 compared with controls with chronic HBV infection, 21% (CI 95%, 3–39%). A high proportion (69%) also had mutations at position 1762 (A → T) and/or 1764 (G → A) in the core promoter region, but the proportion of core promoter mutations was no different from what was found in a control group of HBV carriers without HCC (68%). The pre‐S2 variants, which involve deletions of immunogenic regions, may have a survival advantage as they are mostly found in long‐standing HBV infection. There were no other mutations found frequently within the region coding for the X protein. J. Med. Virol. 71:18–23, 2003. © 2003 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
The core promoter region of hepatitis B virus genomes regulates transcription of the precore and pregenomic mRNAs encoding hepatitis B e antigen (HBeAg) and core antigen that contain target epitopes for cytotoxic T lymphocytes. The prevalence and clinical significance of mutations in this region wer
## Abstract The association of precore stop codon mutation (A1896), dinucleotide mutation (T1762/A1764) in the basic core promoter of hepatitis B virus (HBV) genome, and genotype of HBV with fulminant or subfulminant hepatitis remains controversial. We studied HBV genotypes as well as mutations in
## Abstract Antibody to hepatitis B surface antigen (HBsAg) (anti‐HBs) can exist in patients with chronic hepatitis B virus (HBV) infection. To date, little is known about the association of concurrent HBsAg and anti‐HBs (concurrent HBsAg/ anti‐HBs) with hepatocellular carcinoma (HCC). The aim of t
## Abstract Although occult hepatitis B virus (HBV) infection (HBV‐DNA in serum in the absence of hepatitis B surface antigen [HBsAg]) is common in chronic hepatitis C, its characteristics are not well known. In this work, the presence of HBV‐DNA (by polymerase chain reaction; PCR) and its distribu